Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minetti, C.
Right arrow Articles by Bonilla, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minetti, C.
Right arrow Articles by Bonilla, E.
NEUROLOGY 1994;44:1149
© 1994 American Academy of Neurology

Abnormalities in the expression of ß-spectrin in Duchenne muscular dystrophy

C. Minetti, MD, K. Tanji, MD, P. Gasparo Rippa, MD, G. Morreale, MD, G. Cordone, MD and E. Bonilla, MD

Department of Neurology (Drs. Minetti, Tanji, Gasparo Rippa, and Bonilla), College of Physicians and Surgeons of Columbia University, New York, NY, and the Department of Pediatrics (Drs. Minetti, Morreale, and Cordone), Instituto G. Gaslini, Genova, Italy.

We studied (ß-spectrin using an immunologic probe in muscle samples from patients with Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), other disease controls, and normal controls. By immunohistochemistry in DMD samples, ß-spectrin showed reduced or interrupted staining of the entire cell surface or only patches of bright staining at the cell periphery. There were also alterations of ß-spectrin immunostain in fibers that were not degenerating or regenerating. By immunoblotting, the amount of ß-spectrin in muscle was reduced and varied from 52% to 78% of the normal controls. We found normal values of ß-spectrin in BMD and disease controls. These observations indicate that the expression of ß-spectrin in DMD is abnormal and that ß-spectrin immunolabeling is not a good marker for monitoring membrane integrity in DMD muscle.

Address correspondence and reprint requests to Dr. Eduardo Bonilla, Room 5-431, College of Physicians and Surgeons, New York, NY 10032.

Supported by Center Grant NS 11766 from the National Institute of Neurological Diseases and Stroke, by a grant from the Muscular Dystrophy Association (E.B.), and by a grant from the Italian Muscular Dystrophy Telethon, project 31 (C.M.).

Received August 18, 1993. Accepted for publication in final form December 1, 1993.




This article has been cited by other articles:


Home page
JCBHome page
I. N. Rybakova, J. R. Patel, and J. M. Ervasti
The Dystrophin Complex Forms a Mechanically Strong Link Between the Sarcolemma and Costameric Actin
J. Cell Biol., September 5, 2000; 150(5): 1209 - 1214.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
M. W. Williams and R. J. Bloch
Extensive but Coordinated Reorganization of the Membrane Skeleton in Myofibers of Dystrophic (mdx) Mice
J. Cell Biol., March 22, 1999; 144(6): 1259 - 1270.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by AAN Enterprises, Inc.